NCT00636571
- Conditions
- Behavior, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Duke University Health System Preston Robert Tisch Brain Tumor Center Durham, North Carolina, United States
Clinical trial condition
Respiratory Tract Neoplasms
Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.
8,094 public trials
1,850 recruiting studies
Respiratory Tract Neoplasms trial results
NCT00997230
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Aachen, Germany
- Research Site Amberg, Germany
- Research Site Ansbach, Germany
- Research Site Aschaffenburg, Germany
NCT00132522
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +37 more
- Locations
-
- City of Hope Durate, California, United States
- Dartmouth Medical School, Pharmacology & Toxicology Dept. of Medicine Lebanon, New Hampshire, United States
- Fox Chase Cancer Oncology Department of Medical Oncology Philadelphia, Pennsylvania, United States
- University of Wisconsin Division of Gynecologic Oncology Madison, Wisconsin, United States
NCT00413283
- Conditions
- Blood Platelet Disorders, Bronchial Neoplasms, Cancer, +18 more
- Locations
-
- Research Site Glendale, Arizona, United States
- Research Site Glendale, Arizona, United States
- Research Site Anaheim, California, United States
- Research Site Anaheim, California, United States
NCT01373320
- Conditions
- Behavior, Breast Cancer, Breast Diseases, +35 more
- Locations
-
- Faith Moves Mountains Whitesburg, Kentucky, United States
NCT00563420
- Conditions
- Lung Diseases, Lung Neoplasms, Neoplasms, +4 more
- Locations
-
- Queen Mary Hospital Hong Kong, China
NCT00016237
- Conditions
- Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +27 more
- Locations
-
- Lombardi Cancer Center Washington D.C., District of Columbia, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT00973440
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC
NCT00633529
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- Cancer Centers of Florida Ocoee, Florida, United States
- Central Indiana Cancer Centers Indianapolis, Indiana, United States
- New York Oncology Hematology P.C. Albany, New York, United States
- Mary Crowley Medical Research Center Dallas, Texas, United States
NCT00243347
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Research Site Houston, Texas, United States
- Research Site Barcelona, Spain